Meanwhile, many studies based on mRNA quantification platforms identified mRNA expression biomarkers in AML, such as BAALC, ERG, MECOM/EVI1 and WT1, which could offer additional prognostic values to improve current stratification system [15–21]. The gene discussed is MECOM; the disease is acute myeloid leukemia.